Hennion & Walsh Asset Management Inc. Sells 49 Shares of Humana Inc. (NYSE:HUM)

Hennion & Walsh Asset Management Inc. reduced its stake in Humana Inc. (NYSE:HUM) by 1.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,971 shares of the insurance provider’s stock after selling 49 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Humana were worth $1,030,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. First Financial Corp IN increased its stake in Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after purchasing an additional 23 shares in the last quarter. Aurora Investment Counsel lifted its position in Humana by 1.3% in the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after acquiring an additional 29 shares in the last quarter. Walker Financial Services Inc. boosted its stake in Humana by 3.9% in the 4th quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock worth $364,000 after purchasing an additional 30 shares during the period. Signaturefd LLC increased its holdings in Humana by 1.2% during the 4th quarter. Signaturefd LLC now owns 2,634 shares of the insurance provider’s stock worth $1,206,000 after purchasing an additional 30 shares in the last quarter. Finally, Brighton Jones LLC raised its stake in shares of Humana by 6.8% in the 4th quarter. Brighton Jones LLC now owns 470 shares of the insurance provider’s stock valued at $215,000 after purchasing an additional 30 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently issued reports on HUM shares. Argus downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. The Goldman Sachs Group reduced their target price on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Barclays lowered their price target on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Finally, Wells Fargo & Company reduced their price objective on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Fourteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $409.55.

Humana Stock Down 0.0 %

HUM stock opened at $373.49 on Tuesday. The business’s fifty day moving average price is $343.78 and its two-hundred day moving average price is $351.23. The stock has a market capitalization of $45.01 billion, a price-to-earnings ratio of 23.26, a PEG ratio of 2.16 and a beta of 0.51. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the previous year, the company earned $9.38 EPS. The business’s revenue was up 10.7% on a year-over-year basis. On average, equities analysts anticipate that Humana Inc. will post 16.27 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a yield of 0.95%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.